Program
All times are in EDT.
8:30 am – 9:30 am: Registration
8:30 am – 9:30 am: Refreshment
- 9:00 am – 9:10 am: Opening Remarks and Welcome
- Birol Emir, ASA CT Chapter Vice President
- Steve Ma, Yale University School of Public Health
- 9:10 am – 12:00 pm: Scientific Session I
- 9:10 am – 9:55 am: Mark van der Laan, UC Berkeley
- Super-Efficient Estimation of Average Treatment Effect based on Randomized Controlled Trial Augmented with External Controls or Observational Study Learning
- 10:00 am – 10:45 am: Issa Dahabreh, Harvard University
- Advancing Clinical Development through Real-World Data, AI and Machine Learning.
- 11:00 am – 11:45 am: Mingyang Shan, Eli Lily
- Sensitivity Analysis Strategies for Unmeasured Confounding when Integrating External Controls in Randomized Controlled Trials
- 9:10 am – 9:55 am: Mark van der Laan, UC Berkeley
12:00 pm – 1:00 pm: Lunch
- 1:00 pm – 3:30 pm: Scientific Session II
- 1:00 pm – 1:40 pm: Pallavi Mishra-Kalyani, US FDA
- Regulatory and Statistical Considerations for Non-randomized Comparative Trials in Drug Development
- 1:50 pm – 2:30 pm: Javier Cabrera, Rutgers University
- New proposals in clinical study design based on applications of differential Hermite and propensity scores indices.
- 1:00 pm – 1:40 pm: Pallavi Mishra-Kalyani, US FDA
2:40 pm – 3:15 pm: Discussion, Demissie Alemayehu, Pfizer Inc
- 3:15 pm – 3:30 pm: Closing Remarks